Biobot Surgical logo

Biobot Surgical

Medical Device

11-50 Employees

0.0 (Glassdoor)

Unclaimed
Page has not been claimed by the company yet.

About Biobot Surgical

 Biobot Surgical Pte Ltd was incorporated in 2007 in Singapore, and became a member of ZIG Ventures since 2013. 

To ensure success, a team of talents has been put together in the areas of robotic design and technology, medical image processing, software development and clinical application. 

To date, the iSR’obot Mona Lisa has obtained key regulatory approvals, including Europe (CE mark), U.S.A (US FDA), Australia (TGA) and Singapore (HSA) and is being used in some of the most prestigious hospitals around the world. 

Striving to become the gold standard in diagnosis and prognosis of prostate cancer, the Mona Lisa’s development has been a process of evolution and is the latest in our state of the art new generation designs. 

Biobot Surgical Salaries

Software Engineer

Mid | $3000 - $5000

Biobot Surgical Reviews

ADD A REVIEW

Biobot Surgical Careers and Jobs (0)

There are no active jobs right now, but don't let it stop you!

Explore other jobs

Biobot Surgical Culture

Biobot Surgical has not added their culture yet, add them for FREE now!

Biobot Surgical Employee Benefits

Biobot Surgical has not added their benefits yet, add them for FREE now!

Biobot Surgical Insights

Team Trends


Team Breakdown


Company


Frequently Asked Questions

Biobot Surgical has 11-50 employees globally.

More about Biobot Surgical: Salaries | Reviews | Jobs | Culture | Benefits
 Biobot Surgical Pte Ltd was incorporated in 2007 in Singapore, and became a member of ZIG Ventures since 2013. 

To ensure success, a team of talents has been put together in the areas of robotic design and technology, medical image processing, software development and clinical application. 

To date, the iSR’obot Mona Lisa has obtained key regulatory approvals, including Europe (CE mark), U.S.A (US FDA), Australia (TGA) and Singapore (HSA) and is being used in some of the most prestigious hospitals around the world. 

Striving to become the gold standard in diagnosis and prognosis of prostate cancer, the Mona Lisa’s development has been a process of evolution and is the latest in our state of the art new generation designs.